HIND: Vyome Therapeutics Sotuvga nisbatan narx

ReShape Lifesciences (HIND) kompaniyasining korporativ logotipi

Vyome Holdings Inc klinik sinovlar va mahsulot ishlab chiqarishni tashqi pudratchilarga topshiradi, bu esa yetkazib beruvchilarga kuchli bog'liqlikni yuzaga keltiradi. GURU.Markets platformasidagi P/S koeffitsiyenti tendentsiyasi ushbu jarayonni vizuallashtiradi va joriy ko'rsatkich 72.70 darajasida turibdi. Kompaniya, shuningdek, klinikalar bilan hamkorlikda semizlikning minimal invaziv davolash usullarini joriy qilmoqda, shu bilan birga kelajakda immunoterapiya ishlab chiqarishni kengaytirish uchun o'z ob'ektlarini modernizatsiya qilmoqda.

ReShape Lifesciences - HIND Kapitalizatsiyaning daromadga nisbati (davr: 16.08.2025 - 18.11.2026)

reshapelifesciences.com (HIND) kompaniyasi koʻrsatkichlari kesimi va tahlili

Kompaniyaning umumiy tahlili:HIND - ReShape Lifesciences
Vyome Holdings Inc seriyali mahsuloti

P/S koeffitsiyenti daromadning bir birligining bozor qiymatini belgilaydi, bu esa narx koridorlari va eksport salohiyatini tahlil qilish orqali biznesning adolatli baholash chegaralarini aniqlash imkonini beradi. P/S koeffitsiyentining tarixiy o'rtacha qiymatidan chetlashishini tahlil qilish orqali investor aktivning haddan tashqari sotib olinganligini baholaydi va bunda Vyome Holdings Inc. (HIND) ning kimyoviy chiqindilarni utilizatsiya qilish bo'yicha qat'iy ESG standartlarining kompaniyaning uzoq muddatli kapitalizatsiyasiga ta'sirini hisobga oladi.

Vyome Holdings Inc kimlar bilan raqobatlashadi

argenx - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (biontech.de)|Abivax Corp (ABVX) - Sotuvga nisbatan narx|ADMA Corp - P/S multiplikatori|Narxning sotuvga nisbati PTGX|Immunovant Inc (IMVT) - Narxning daromadga nisbati|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols Biemat) - P/S multiplikatori|P/S multiplikatori Adaptive Biotechnologies Inc.|Narxning daromadga nisbati Celldex Therapeutics (CLDX)|Narx/daromad koeffitsiyenti auriniapharma.com|Narxning daromadga nisbati BioCryst Pharmaceuticals BCRX|Bozor kapitallashuvining daromadga nisbati VERA|Dianthus Pharma - P/S multiplikatori|PHVS - P/S multiplikatori|ABCL: P/S multiplikatori|TRML (Tourmaline Bio, Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati Intrexon|PHAR - Narx/daromad multiplikatori|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio Corp)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Narx/daromad koeffitsiyenti immunome.com (IMNM)|Gossamer Bio Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati KALV (KalVista Pharmaceuticals, Inc.)|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharmaceuticals Inc|Kapitalizatsiyaning daromadga nisbati SVRA|Kapitalizatsiyaning daromadga nisbati Rigel Pharmaceuticals (RIGL)|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|Narxning daromadga nisbati enGene Corp ENGN|Narx/daromad koeffitsiyenti RAPT Therapeutics, Inc. (RAPT)|Aerovate - P/S multiplikatori|ACRS - P/S multiplikatori|KYTX (Kyverna Therapeutics) - Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx Tiziana Life Sciences Ltd. (TLSA)|Kapitalizatsiyaning daromadga nisbati CABA|Ventyx Biosciences (VTYX) - Narx/daromad koeffitsiyenti|P/S multiplikatori THTX|AVTX (Avalo Therapeutics, Inc) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ELDN (eledon.com)|AGEN - Kapitalizatsiyaning daromadga nisbati|CLYM - Narxning daromadga nisbati|Narxning sotuvga nisbati ZURA|ATYR: P/S multiplikatori|Adagene Corp (ADAG) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati IMA|Shattuck Labs, Inc. - Narxning sotuvga nisbati|Narxning daromadga nisbati Equillium Inc (EQ)|P/S multiplikatori Connect Biopharma Holdings (CNTB)|Narxning daromadga nisbati Immunic, Inc. IMUX|P/S multiplikatori Atara Biotherapeutics ATRA|IFRX - Narxning daromadga nisbati|XFOR: Narxning daromadga nisbati|ACET: P/S multiplikatori|CELU - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati inmunebio.com|Kapitalizatsiya va daromad nisbati BRNS (barinthusbio.com)|P/S multiplikatori KZR|P/S multiplikatori SAB Biotherapeutics, Inc (SABS)|P/S multiplikatori AKTX (Akari Therapeutics, Plc)|P/S multiplikatori enlivex.com ENLV|QTTB: Kapitalizatsiyaning daromadga nisbati|GOVX - P/S multiplikatori|Edesa Biotech Inc (EDSA) - Narxning daromadga nisbati|IBIO - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati carismatx.com|XTLB: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Bolt Biotherapeutics Inc. (BOLT)|HCW Biologics - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati aptevotherapeutics.com APVO|AIM - Kapitalizatsiyaning daromadga nisbati|Aditxt - P/S multiplikatori|Narx/daromad koeffitsiyenti GRI Bio Corporation GRI|xortx.com (XRTX) - Narxning daromadga nisbati|revbiosciences.com (REVB) - P/S multiplikatori|INDP (Indaptus Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Scinai Immunotherapeutics Ltd (SCNI)|Narxning daromadga nisbati CalciMedica Inc (CALI)|AFMD (Affimed NV) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos Inc.)|P/S multiplikatori HOOKIPA HOOK|IGMS: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iTeos)|OCEA: P/S multiplikatori|TCBP (TC BioPharm Ltd) - Narxning daromadga nisbati|THRD (Third Harmonic Bio Inc) - P/S multiplikatori